Here, we identified a novel target gene CDK5RAP2, whose alternative splicing was regulated by RBM39 and MORC2, contributing to a better understanding of the mechanisms of RBM39 and MORC2 in colon cancer. This evidence concerns the gene RBM39 and malignant colon neoplasm.